c-Myc tag Peptide: Benchmark Reagent for Anti-c-Myc Antibody Displacement

Executive Summary: The c-Myc tag Peptide (SKU: A6003, APExBIO) is a synthetic peptide comprising amino acids 410–419 of human c-Myc. It is validated for displacing c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays, enabling specific detection and quantitative recovery (APExBIO, 2024). The c-Myc protein is a proto-oncogene transcription factor critical in cell proliferation, apoptosis, differentiation, and stem cell regulation, with dysregulation linked to cancer (Wu et al., 2021, DOI). The peptide is highly soluble in DMSO (≥60.17 mg/mL), moderately in water (≥15.7 mg/mL, ultrasonic), and insoluble in ethanol, allowing flexible assay integration. Recommended storage is desiccated at -20°C; peptide solutions are not stable for long-term storage. The product is for research use only, not diagnostic or therapeutic applications.

Biological Rationale

The c-Myc gene (MYC) encodes a nuclear transcription factor involved in the regulation of genes that control cell growth, proliferation, apoptosis, and differentiation (Wu et al., 2021, DOI). c-Myc is classified as a proto-oncogene; its overexpression or dysregulation is a driver in multiple human cancers. In normal physiology, c-Myc modulates cyclin expression, ribosomal biogenesis, and metabolic pathways. The C-terminal region, comprising residues 410–419, represents a highly immunogenic epitope used in protein tagging strategies (APExBIO, 2024). Synthetic c-Myc tag peptides are essential tools in molecular biology for the controlled displacement of c-Myc-tagged fusion proteins during immunoassays, ensuring specificity and reproducibility of detection.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide functions as a competitive inhibitor during immunoassays. When introduced to a system containing anti-c-Myc antibodies bound to c-Myc-tagged fusion proteins, the peptide competes for antibody binding sites due to its identical epitope sequence. This competition results in the displacement of the fusion protein from the immobilized antibody, enabling its elution and subsequent analysis (APExBIO, 2024). The specificity of this displacement is due to the unique amino acid sequence (EQKLISEEDL) present in the peptide, which matches the antigenic determinant recognized by widely used monoclonal anti-c-Myc antibodies (e.g., 9E10). The competitive inhibition principle underlies the peptide's utility in immunoprecipitation, Western blotting, and ELISA workflows.

Evidence & Benchmarks

• The c-Myc tag Peptide displaces c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays with high specificity (APExBIO protocol, product page).
• c-Myc is a master regulator of transcription, modulating cell cycle, proliferation, and apoptosis, and is frequently amplified in human cancers (Wu et al., 2021, DOI).
• The peptide is soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonic treatment, but insoluble in ethanol (APExBIO datasheet, source).
• Storage at -20°C under desiccated conditions preserves peptide integrity; solution stability is limited, and repeated freeze-thaw cycles are discouraged (APExBIO, product page).
• Anti-c-Myc antibody binding can be specifically inhibited by the c-Myc peptide, enabling elution of native complexes in co-immunoprecipitation experiments (related article), which this article extends by detailing performance parameters and solubility data.

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily applied in immunoassays to displace c-Myc-tagged proteins from antibodies for elution and downstream analysis. Its use is fundamental in optimizing co-immunoprecipitation, ChIP, and Western blot protocols for tagged protein studies (Optimizing Immunoassays...). In contrast to broader mechanistic reviews, this article provides detailed solubility, storage, and competitive inhibition data.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide is not a diagnostic or therapeutic agent; it is for research use only (APExBIO, 2024).
• It does not inhibit endogenous c-Myc transcription factor activity in living cells.
• The peptide cannot displace proteins tagged with non-c-Myc epitopes (e.g., HA, FLAG).
• Solubility in ethanol is negligible; DMSO or water (with ultrasonic treatment) must be used.
• Peptide solutions are unstable for long-term storage; prepare fresh aliquots as needed.

Workflow Integration & Parameters

The c-Myc tag Peptide is compatible with standard immunoassay workflows. For competitive elution, the peptide is typically used at concentrations ranging from 0.1 to 1 mg/mL, depending on antibody affinity and assay volume. Prepare stock solutions in DMSO (≥60.17 mg/mL) or water (≥15.7 mg/mL, ultrasonic treatment). Avoid ethanol as a solvent due to insolubility. Store dry aliquots at -20°C, desiccated; do not freeze-thaw repeatedly. For best results, add peptide to antibody-bound complexes, incubate 30–60 minutes at 4°C, and collect eluate. The reagent is validated for use with monoclonal anti-c-Myc antibodies (e.g., clone 9E10). For protocol optimization and troubleshooting, see scenario-based guides in Optimizing Immunoassays and Transcription Factor Studies.

Conclusion & Outlook

The c-Myc tag Peptide from APExBIO is a benchmark reagent for the selective displacement of c-Myc-tagged proteins in immunoassays, enabling reproducible and specific antibody binding inhibition. Its well-characterized solubility and storage parameters facilitate flexible integration into diverse workflows. While not suitable for diagnostic or therapeutic use, it remains a critical tool for mechanistic studies of transcription factor regulation, protein interactions, and cancer biology. For further mechanistic insights and translational applications, refer to The c-Myc Tag Peptide: Mechanistic Insights and Strategic Applications, which this article updates with current product specifications and evidence benchmarks.